The purpose of this pilot study is to test the safety and feasibility of using two or three research modules in conjunction with an automated insulin delivery device (AID).
This concept is implemented in the Adaptive Biobehavioral Control (ABC) system - ABC will use human-machine co-adaptation of AID, recognizing both the necessity for the control algorithm to adapt to changes in human physiology, and the necessity for the person to adapt to AID action. ABC will be implemented on the Web Information Tool (WIT) platform/system and includes the following modules to be used alongside the automated insulin delivery device facilitating behavioral adaptation:
Design: Two-week baseline use of personal AID system followed by randomization 1:1 into two groups.
Condition | Diabetes Prevention, Autoimmune Disease, Diabetes Mellitus Types I and II, Autoimmune disease, type 1 diabetes, diabetes mellitus type 1, iddm, Diabetes Mellitus, Type 1, diabetes type 1, type i diabetes mellitus, Diabetes Mellitus, Diabetes (Pediatric), insulin-dependent diabetes, type 1 diabetes mellitus, Insulin dependent diabetes mellitus |
---|---|
Treatment | Web Simulation Tool (WST), Behavioral Adaptation Module (BAM), Auto Titration Module (ATM), Automated Insulin Delivery (AID) System |
Clinical Study Identifier | NCT04784637 |
Sponsor | University of Virginia |
Last Modified on | 24 May 2022 |
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.